Literature DB >> 1665909

Type I and type II photosensitization by the antibacterial drug nalidixic acid. A laser flash photolysis study.

G Vermeersch1, J C Ronfard-Haret, M Bazin, V Carillet, P Morliere, R Santus.   

Abstract

The 355 nm laser flash photolysis of nalidixic acid at pH 9.2 leads to the formation of the nalidixate anion triplet state (absorption lambda max = 620 nm; 5700 less than or equal to epsilon T less than or equal to 9000 M-1cm-1; 0.6 less than or equal to phi T less than or equal to 1). The first order triplet state decay (kT = 7.7 x 10(3) s-1) is accompanied by a diffusion controlled triplet-triplet annihilation. Oxygen efficiently quenches the triplet state (k = 3.2 x 10(9) M-1s-1). The nalidixate radical dianion (absorption lambda max = 650 nm; epsilon = 3000 M-1cm-1) is produced by the diffusion controlled reductive quenching of the triplet state by tryptophan and tyrosine. The superoxide anion (O2-.) is produced by diffusion controlled reaction of the radical dianion with oxygen. The O2-. is characterized by its reactions with ferricytochrome c and superoxide dismutase. The physiological form of nalidixic acid is thus a good Type I and Type II photosensitizer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665909     DOI: 10.1111/j.1751-1097.1991.tb02072.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  2 in total

Review 1.  Ophthalmic light sensitive nanocarrier systems.

Authors:  Jennifer G Christie; Uday B Kompella
Journal:  Drug Discov Today       Date:  2008-02-01       Impact factor: 7.851

2.  Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense RNA by the soxRS locus.

Authors:  J H Chou; J T Greenberg; B Demple
Journal:  J Bacteriol       Date:  1993-02       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.